Keywords: Tumors (Post-Treatment), DSC & DCE Perfusion
Motivation: Glioblastoma (GBM) has poor survival rates, and DCE-MRI aids in understanding tumor vascularity. However, selecting an optimal pharmacokinetic (PK) model remains challenging.
Goal(s): To identify the best-fitting PK model for GBM regions using an Akaike Information Criterion (AIC)-based parsimonious model selection.
Approach: DCE-MRI data from 46 GBM patients were segmented into enhancing, non-enhancing, and edema regions. Five PK models were fitted per region, with AIC used to select the best model per voxel. A parsimonious model was created from these best-fits.
Results: The parsimonious model outperformed individual models across regions, with Extended Tofts, 2CXM and Shutter-Speed models excelling in enhancing/non-enhancing regions and edema.
Impact: This study improves GBM assessment by optimizing DCE-MRI PK model selection. It tailors models to specific tumor regions, enabling more accurate quantification of tumor characteristics, aiding diagnosis & treatment planning. This approach can be applied to other tumors and imaging protocols.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords